SNMMI publishes appropriate use criteria for bone scintigraphy in prostate and breast cancer

(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging has published appropriate use criteria (AUC) for bone scintigraphy (scans to identify bone metastases) in patients with prostate or breast cancer. This is the first in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity under the Medicare Appropriate Use Criteria program for advanced diagnostic imaging.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news